Tag:

erectile dysfunction

Latest Headlines

Latest Headlines

Auxilium aims Stendra's sexy March Madness ads at stiff ED competition

It's March Madness in the NCAA, which means lots of men glued to the games. What better time for an underdog erectile dysfunction drug to tout itself? That's the theory at Auxilium, which is launching an ad campaign for the ED remedy Stendra.

Sanofi signs on to sell Vivus ED drug in emerging markets

After rolling out its weight-loss drug Qsymia solo, a move that spurred plenty of shareholder discontent, Vivus is taking marketing partnerships for erectile dysfunction drug Stendra seriously. Thursday, it announced a deal with Sanofi that covers licensing and commercialization in emerging markets.

Pfizer's Viagra patent in Europe expires today

It's party time in Europe for generic drugmakers. The patent for Pfizer's erectile dysfunction drug Viagra falls off today and generics are expected to soon flood the market.

Pfizer combats online fakes with direct-to-patient Viagra sales

Pfizer ($PFE) is testing the online-sales waters with a new program to sell Viagra directly to consumers. It's a natural choice: Makers of erectile dysfunction drugs have been working on packaging and formulation changes to make it easier--and more discreet--for men to use them.

Study: ED drugmakers aren't properly policing their TV ads

Embarrassed by the ads for erectile dysfunction drugs that pop up at the most inopportune moments? A new study found that the television commercials are indeed airing at family-viewing times--contrary to drugmakers' express promises to refrain.

Acorda's drug treats nerve damage-related ED in preclinical test

Acorda Therapeutics' new neuregulin drug helped treat erectile dysfunction in rats with nerve damage, according to preclinical data the company presented at a recent conference.

Acorda's drug treats nerve damage-related ED in preclinical test

Acorda Therapeutics' new neuregulin drug helped treat erectile dysfunction in rats with nerve damage, according to preclinical data the company presented at a recent conference.

Vivus gets ED drug approval, spurring fresh talk of a deal

Vivus has won its first drug approval. The FDA issued word this afternoon that it had stamped its OK on Stendra (avanafil), an erectile dysfunction treatment designed to spur a quicker response for men. 

Ampio to seek foreign OKs for premature ejaculation drug

Ampio Pharmaceuticals ($AMPE) is gearing up to seek international regulatory approval for its drug to treat premature ejaculation. The company disclosed Dec. 5 that it is preparing for this, in part,

Lilly's ED treatment Cialis wins prostate indication

Eli Lilly ($LLY) just won FDA approval for an enlarged-prostate treatment. That's a bit of good news that only goes so far, as the market for benign prostatic hyperplasia treatments is rather full.